HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guy Van Camp Selected Research

Pergolide (Permax)

6/2009Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.
11/2008Pergolide and valvular heart disease: the lower the better?
9/2007In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology.
4/2004Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guy Van Camp Research Topics

Disease

29Hearing Loss (Hearing Impairment)
08/2019 - 05/2002
22Neoplasms (Cancer)
01/2022 - 09/2011
15Otosclerosis
04/2022 - 04/2006
10Autosomal Dominant 5 Deafness
01/2018 - 07/2003
9Heart Valve Diseases (Valvular Heart Disease)
10/2018 - 04/2004
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 10/2015
6Heart Failure
01/2022 - 12/2007
6Nonsyndromic Deafness
01/2016 - 08/2003
5Adenocarcinoma
01/2022 - 01/2017
5Breast Neoplasms (Breast Cancer)
01/2018 - 06/2012
5Aortic Valve Insufficiency (Aortic Regurgitation)
06/2009 - 09/2007
4Sensorineural Hearing Loss
01/2021 - 06/2005
4Malignant Mesothelioma
01/2021 - 10/2016
4Mitral Valve Insufficiency (Mitral Regurgitation)
10/2017 - 09/2007
4Deafness (Deaf Mutism)
01/2011 - 01/2004
3Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 04/2016
3Primitive Neuroectodermal Tumors (PNET)
01/2018 - 04/2015
3Inflammation (Inflammations)
09/2016 - 01/2010
3Noise-Induced Hearing Loss (Acoustic Trauma)
09/2012 - 08/2006
3Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
04/2009 - 09/2007
2Myocardial Infarction
01/2022 - 04/2002
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2014
2Mesothelioma
01/2021 - 10/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 09/2008
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019 - 01/2018
2Autosomal Recessive Deafness
01/2017 - 07/2005
2Triple Negative Breast Neoplasms
01/2014 - 01/2014
2type 1 Stickler syndrome
07/2011 - 09/2006
2Conductive Hearing Loss
09/2010 - 12/2009
2Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
08/2010 - 03/2010
2Atrial Fibrillation
11/2008 - 06/2008
1Stroke (Strokes)
01/2022
1Severe Acute Respiratory Syndrome
05/2021
1Common Cold
05/2021
1Infections
05/2021
1Carcinoma (Carcinomatosis)
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
11/2020
1Carcinogenesis
11/2019
1Intestinal Neoplasms (Intestinal Cancer)
08/2019
1Bone Resorption
01/2019

Drug/Important Bio-Agent (IBA)

14DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2003
14Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2003
12Capsules (Microcapsules)IBA
08/2019 - 09/2007
10Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2010
9Connexin 26IBA
10/2018 - 04/2003
4Cell-Free Nucleic AcidsIBA
01/2022 - 01/2018
4AsbestosIBA
01/2021 - 10/2016
4Messenger RNA (mRNA)IBA
01/2017 - 01/2007
4Pharmaceutical PreparationsIBA
05/2013 - 09/2007
4Pergolide (Permax)FDA Link
06/2009 - 04/2004
3PotassiumIBA
09/2012 - 08/2006
3NucleotidesIBA
07/2011 - 01/2007
2Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 11/2019
2Biological ProductsIBA
01/2019 - 03/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2018
2RNA (Ribonucleic Acid)IBA
01/2018 - 01/2014
2withaferin AIBA
01/2018 - 01/2014
2ErbB Receptors (EGF Receptor)IBA
01/2018 - 10/2015
2Complement System Proteins (Complement)IBA
01/2018 - 10/2004
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 11/2011
2Hormones (Hormone)IBA
01/2017 - 01/2014
2Carrier Proteins (Binding Protein)IBA
01/2017 - 10/2012
2Mutant Proteins (Protein, Mutant)IBA
01/2012 - 09/2011
2FluoridesIBA
06/2010 - 12/2009
2Transforming Growth Factor beta1 (TGF beta 1)IBA
12/2009 - 09/2007
2Serotonin (5 Hydroxytryptamine)IBA
09/2009 - 09/2007
2Amino AcidsFDA Link
03/2009 - 05/2002
2Myosins (Myosin)IBA
01/2009 - 04/2004
2DobutamineFDA LinkGeneric
09/2008 - 04/2002
2Transforming Growth Factor beta (TGF-beta)IBA
04/2008 - 09/2007
2CollagenIBA
09/2006 - 04/2006
1Aggrecans (Aggrecan)IBA
04/2022
1Chromogranin AIBA
01/2022
1Phosphopyruvate Hydratase (Enolase)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
05/2021
1InterferonsIBA
05/2021
1PolyphenolsIBA
01/2021
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1SirtuinsIBA
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2021
1mangiferinIBA
01/2021
1DecitabineFDA Link
11/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2020
1Blood Glucose (Blood Sugar)IBA
01/2020
1AzoxymethaneIBA
08/2019
15' Untranslated Regions (5' UTR)IBA
08/2019
13' Untranslated Regions (3' UTR)IBA
08/2019
1Aspartic Acid (Aspartate)FDA Link
01/2019
1Platelet-Derived Growth FactorIBA
01/2019
1Serine (L-Serine)FDA Link
01/2019

Therapy/Procedure

13Therapeutics
01/2022 - 05/2013
3Conservative Treatment
01/2022 - 04/2016
2Cardiac Resynchronization Therapy
01/2019 - 04/2011
2Catheters
01/2018 - 12/2007
2Patient Readmission
10/2017 - 11/2016
2Drug Therapy (Chemotherapy)
08/2014 - 07/2010
2Punctures
11/2008 - 06/2008
1Immunomodulation
05/2021
1Immunotherapy
01/2021